Stay updated on Menin Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedClinicalTrials.gov’s page footer version was updated from “v3.5.2” to “v3.5.3,” indicating a site software revision/maintenance release rather than a change to the underlying trial information.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded updates dated 2026-04-14, 2026-04-09, and 2026-04 with Revision: v3.5.2; removed updates dated 2025-10-23, 2025-10-21, and 2025-10 with Revision: v3.5.0.SummaryDifference0.3%

- Check38 days agoChange DetectedAdded the citation High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition (Mol Cell Proteomics, 2026 Mar;25(3):101522) with Epub 2026-01-30. The entry previously listed 'Online ahead of print' and now reflects the official publication date.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedA bibliographic citation was added with revised formatting and the study record version was updated to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No user-facing changes to the study details page were observed.SummaryDifference0.1%

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.